Moberg Pharma AB (OMX: MOB) today announces that a new terbinafine supplier has been secured for MOB-015 (drug for nail fungus). As a result, terbinafine availability is no longer a limiting factor ...

Nail fungus is a frustratingly common ailment — about 10% of people are expected to get it at some point in their lives.